Committee Opinion No. 670: Immediate Postpartum Long-Acting Reversible Contraception
- PMID: 27454734
- DOI: 10.1097/AOG.0000000000001587
Committee Opinion No. 670: Immediate Postpartum Long-Acting Reversible Contraception
Abstract
Immediate postpartum long-acting reversible contraception (LARC) has the potential to reduce unintended and short-interval pregnancy. Women should be counseled about all forms of postpartum contraception in a context that allows informed decision making. Immediate postpartum LARC should be offered as an effective option for postpartum contraception; there are few contraindications to postpartum intrauterine devices and implants. Obstetrician-gynecologists and other obstetric care providers should discuss LARC during the antepartum period and counsel all pregnant women about options for immediate postpartum initiation. Education and institutional protocols are needed to raise clinician awareness and to improve access to immediate postpartum LARC insertion. Obstetrician-gynecologists and other obstetric care providers should incorporate immediate postpartum LARC into their practices, counsel women appropriately about advantages and risks, and advocate for institutional and payment policy changes to support provision.
Similar articles
-
Committee Opinion No. 670 Summary: Immediate Postpartum Long-Acting Reversible Contraception.Obstet Gynecol. 2016 Aug;128(2):422-423. doi: 10.1097/AOG.0000000000001583. Obstet Gynecol. 2016. PMID: 27454730
-
Society for Maternal-Fetal Medicine (SMFM) Consult Series #48: Immediate postpartum long-acting reversible contraception for women at high risk for medical complications.Am J Obstet Gynecol. 2019 May;220(5):B2-B12. doi: 10.1016/j.ajog.2019.02.011. Epub 2019 Feb 7. Am J Obstet Gynecol. 2019. PMID: 30738885
-
Advances in contraception: new options for postpartum women.Expert Opin Pharmacother. 2017 May;18(7):677-688. doi: 10.1080/14656566.2017.1316370. Epub 2017 Apr 17. Expert Opin Pharmacother. 2017. PMID: 28375776 Review.
-
Implementing best practices for the provision of long-acting reversible contraception: a survey of obstetrician-gynecologists.Contraception. 2019 Aug;100(2):123-127. doi: 10.1016/j.contraception.2019.03.053. Epub 2019 Apr 11. Contraception. 2019. PMID: 30981843
-
Immediate postpartum provision of long-acting reversible contraception.Curr Opin Obstet Gynecol. 2015 Dec;27(6):460-4. doi: 10.1097/GCO.0000000000000224. Curr Opin Obstet Gynecol. 2015. PMID: 26536209 Review.
Cited by
-
Expanding access to postpartum contraception.Curr Opin Obstet Gynecol. 2024 Oct 1;36(5):331-337. doi: 10.1097/GCO.0000000000000982. Epub 2024 Aug 2. Curr Opin Obstet Gynecol. 2024. PMID: 39109628 Free PMC article. Review.
-
Does reversible postpartum contraception reduce the risk of pregnancy condition recurrence? A longitudinal claims-based study from Maine.Ann Epidemiol. 2024 Aug;96:58-65. doi: 10.1016/j.annepidem.2024.06.001. Epub 2024 Jun 15. Ann Epidemiol. 2024. PMID: 38885800
-
The prevalence of contraceptive use among postpartum women and its associated factors during the early phase of COVID-19 outbreak: a time series study.Reprod Health. 2024 Jun 6;21(1):80. doi: 10.1186/s12978-024-01803-3. Reprod Health. 2024. PMID: 38840252 Free PMC article.
-
Levonorgestrel Implant Continuation among Postpartum Women Admitted to the Department of Obstetrics and Gynecology of a Tertiary Care Centre.JNMA J Nepal Med Assoc. 2023 Sep 1;61(265):714-717. doi: 10.31729/jnma.8254. JNMA J Nepal Med Assoc. 2023. PMID: 38289806 Free PMC article.
-
Results of Immediate Postpartum Long Acting Reversible Contraception Provision After Expanded Reimbursement Policy Implementation at an Academic Medical Institution.Matern Child Health J. 2023 Nov;27(11):1914-1919. doi: 10.1007/s10995-023-03738-w. Epub 2023 Jun 8. Matern Child Health J. 2023. PMID: 37289295 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical

